-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical News February 22
The introduction of the heavy policy, the 20 billion market is facing the changing situation
On February 18, the website of the State Food and Drug Administration published a number of articles on the development of TCM formula granules to further interpret the importance of the formulation of national standards for TCM formula granules.
The national standard of Chinese medicine formula granules will be promulgated soon
A few days ago, the State Food and Drug Administration, the State Administration of Traditional Chinese Medicine , the National Health Commission, and the National Medical Insurance Administration jointly issued the "Announcement on Ending the Pilot Work of TCM Formula Granules", and the formulation of national drug standards for TCM formula granules is also on the agenda.
According to the interpretation of the State Food and Drug Administration, the first batch of 160 Chinese medicine formula granules national standards will be released soon.
The formulation of the first batch of national standards for traditional Chinese medicine formula granules implements the management concepts and requirements of "full process management", "standard decoction comparison" and "establishing rigorous quality standards" in the "Technical Requirements for Quality Control and Standard Formulation of Traditional Chinese Medicine Formula Granules".
The goal is to form the "most rigorous standard.
"
The formulation of the first batch of national standards for traditional Chinese medicine formula granules implements the management concepts and requirements of "full process management", "standard decoction comparison" and "establishing rigorous quality standards" in the "Technical Requirements for Quality Control and Standard Formulation of Traditional Chinese Medicine Formula Granules".
The goal is to form the "most rigorous standard.
"
The first batch of national standards for traditional Chinese medicine formula granules has the following five characteristics:
1.
Clarify the varieties of multi-base raw medicinal materials , so that the source of Chinese medicine bases can be controlled more accurately.
Clarify the varieties of multi-base raw medicinal materials , so that the source of Chinese medicine bases can be controlled more accurately.
2.
Fully embody the traditional technique of decoction and ensure that the decoction pieces are fed in sufficient quantities.
Fully embody the traditional technique of decoction and ensure that the decoction pieces are fed in sufficient quantities.
3.
It can effectively distinguish the authenticity of Chinese medicine formula granules and realize the overall quality control of Chinese medicine.
It can effectively distinguish the authenticity of Chinese medicine formula granules and realize the overall quality control of Chinese medicine.
4.
Fully implement the requirements of the new version of "Chinese Pharmacopoeia" for harmful foreign residues, so that Chinese medicine formula granules are more safe.
Fully implement the requirements of the new version of "Chinese Pharmacopoeia" for harmful foreign residues, so that Chinese medicine formula granules are more safe.
5.
Reasonably stipulate the conditions of storage and circulation links to better guarantee the quality of traditional Chinese medicine formula granules.
Reasonably stipulate the conditions of storage and circulation links to better guarantee the quality of traditional Chinese medicine formula granules.
New standards and high requirements, pharmaceutical companies face a new test
The requirements of national standards for enterprises are mainly reflected in two aspects.
One is the requirement for the scale of the enterprise.
The production of Chinese medicine formula granules should follow the concept of whole-process control.
Manufacturers should give priority to the use of Chinese medicinal materials from Chinese medicinal materials planting and breeding bases that meet the requirements of Chinese medicinal materials production quality management standards.
It is recommended to use authentic medicinal materials and self-processed for Chinese medicine formulas.
The decoction pieces of traditional Chinese medicine produced by granules have the complete production capacity of traditional Chinese medicine processing, extraction, separation, concentration, drying, and granulation.
Manufacturers should give priority to the use of Chinese medicinal materials from Chinese medicinal materials planting and breeding bases that meet the requirements of Chinese medicinal materials production quality management standards.
It is recommended to use authentic medicinal materials and self-processed for Chinese medicine formulas.
The decoction pieces of traditional Chinese medicine produced by granules have the complete production capacity of traditional Chinese medicine processing, extraction, separation, concentration, drying, and granulation.
Enterprises are required to have a supporting planting base of Chinese medicinal materials, strengthen the research on the processing technology of Chinese medicinal pieces, the construction of Chinese medicinal materials planting bases, and source control.
The second is the ability to control corporate quality.
In the technical requirements, the concept of "standard decoction" was introduced, and the application of characteristic map quality control technology was stipulated, which strengthened the overall quality control level of traditional Chinese medicine formula granules.
On the basis of the study of exogenous and other harmful residues, unified requirements for pesticide residues, heavy metals and harmful elements, mycotoxins, etc.
, refer to the 2020 edition of the Chinese Pharmacopoeia.
On the basis of the study of exogenous and other harmful residues, unified requirements for pesticide residues, heavy metals and harmful elements, mycotoxins, etc.
, refer to the 2020 edition of the Chinese Pharmacopoeia.
Higher standards will also bring higher costs, which substantially raises the threshold of the Chinese medicine formula granule market.
Although the TCM granule industry has a large number of entrants, only a few can do it on a large scale.
In order to achieve profitability, Chinese medicine formula granule companies need to work together to form an "integrated" scale advantage from the procurement of medicinal materials, process technology to production, quality control, and sales terminals.
In order to achieve profitability, Chinese medicine formula granule companies need to work together to form an "integrated" scale advantage from the procurement of medicinal materials, process technology to production, quality control, and sales terminals.
It is understood that the current Chinese medicine formula granule companies are mainly composed of 6 pilot companies across the country and the gradually opening provincial pilot companies.
The 6 pilot companies account for more than 80% of the market share.
The industry concentration is extremely high, but the industry competition is becoming increasingly fierce.
The 6 pilot companies account for more than 80% of the market share.
The industry concentration is extremely high, but the industry competition is becoming increasingly fierce.
(Source: Compiled by Qianzhan Industry Research Institute)
Large-scale Chinese medicine formula granule companies have established an integrated upstream and downstream industrial platform by opening up the entire industry chain, establishing their own medicinal material cultivation bases and Chinese medicine decoction pieces trading market, stabilizing the quality of Chinese medicine decoction pieces, and strictly controlling product quality from source to sales.
Form a stable and controllable production and sales model for the entire industry chain.
Form a stable and controllable production and sales model for the entire industry chain.
In the past, there have been many companies in the traditional Chinese medicine formula granule industry, but there are only more than 20 companies that really have large-scale product sales.
Most companies have no large-scale product sales, and their licenses are basically in an "idle" state.
Now that the new standard is about to be introduced, there are higher requirements for the scale of the enterprise.
Most companies have no large-scale product sales, and their licenses are basically in an "idle" state.
Now that the new standard is about to be introduced, there are higher requirements for the scale of the enterprise.
The blue ocean of the tens of billions market, many pharmaceutical companies are vying for the first layout
Although the Chinese medicine formula granule market is currently highly concentrated, it still attracts a large number of pharmaceutical companies to enter the market due to the huge market prospects.
Since February last year, a number of listed companies have set up production bases for traditional Chinese medicine formula granules.
According to incomplete statistics from Xinhua News Agency, there are currently more than 60 pharmaceutical companies across the country that have obtained the qualifications for the production of traditional Chinese medicine prescription granules, including the six trial-manufacturing enterprises of Chinese medicine prescription granules initially approved by the State Food and Drug Administration.
According to incomplete statistics from Xinhua News Agency, there are currently more than 60 pharmaceutical companies across the country that have obtained the qualifications for the production of traditional Chinese medicine prescription granules, including the six trial-manufacturing enterprises of Chinese medicine prescription granules initially approved by the State Food and Drug Administration.
On the one hand, traditional Chinese medicine formula granules have a larger sales space than ordinary medicines , and there is no need to participate in national centralized procurement.
Some hospitals can also refer to Chinese medicine decoction pieces into the scope of medical insurance reimbursement.
On the other hand, the superimposed traditional Chinese medicine formula particles are more convenient to carry and equivalent to the efficacy of traditional Chinese medicine preparations.
With the deepening of patient education, the market scale will continue to expand.
Some hospitals can also refer to Chinese medicine decoction pieces into the scope of medical insurance reimbursement.
On the other hand, the superimposed traditional Chinese medicine formula particles are more convenient to carry and equivalent to the efficacy of traditional Chinese medicine preparations.
With the deepening of patient education, the market scale will continue to expand.
According to the analysis of iiMedia.
com, the market size of traditional Chinese medicine formula granules increased from 200 million yuan to 10.
7 billion yuan from 2006 to 2016, with a compound annual growth rate of 48.
9%.
It is expected that the market size of traditional Chinese medicine formula granules will reach 25.
5 billion yuan by 2020.
Some institutions predict that the market size of the Chinese medicine formula granule industry will continue to grow rapidly in the next five years.
It is estimated that by 2023, the industry size will reach 49.
21 billion yuan.
com, the market size of traditional Chinese medicine formula granules increased from 200 million yuan to 10.
7 billion yuan from 2006 to 2016, with a compound annual growth rate of 48.
9%.
It is expected that the market size of traditional Chinese medicine formula granules will reach 25.
5 billion yuan by 2020.
Some institutions predict that the market size of the Chinese medicine formula granule industry will continue to grow rapidly in the next five years.
It is estimated that by 2023, the industry size will reach 49.
21 billion yuan.
2006-2020 market scale and forecast of traditional Chinese medicine formula granules (unit: 100 million yuan)
(Data source: National Bureau of Statistics, iiMedia Data Center)
With the introduction of unified standards, problems that restrict the development of the industry, such as market chaos and repeated waste of research and development, will be resolved.
Future competition requires participation in compliance, competition in technology, and endorsement of strength.
In addition, with the end of the pilot policy, competition in the Chinese medicine formula granule market will become more intense in the future, and the existing pattern is expected to be broken.
Future competition requires participation in compliance, competition in technology, and endorsement of strength.
In addition, with the end of the pilot policy, competition in the Chinese medicine formula granule market will become more intense in the future, and the existing pattern is expected to be broken.
At present, the traditional Chinese medicine formula granule industry is still in its infancy.
The first thing pharmaceutical companies must do is to keep up with policy trends and continuously improve their quality-centric competitiveness in order to share more shares in this tens of billions of market.
The first thing pharmaceutical companies must do is to keep up with policy trends and continuously improve their quality-centric competitiveness in order to share more shares in this tens of billions of market.
Medical News February 22
The introduction of the heavy policy, the 20 billion market is facing the changing situation
On February 18, the website of the State Food and Drug Administration published a number of articles on the development of TCM formula granules to further interpret the importance of the formulation of national standards for TCM formula granules.
The national standard of Chinese medicine formula granules will be promulgated soon
A few days ago, the State Food and Drug Administration, the State Administration of Traditional Chinese Medicine , the National Health Commission, and the National Medical Insurance Administration jointly issued the "Announcement on Ending the Pilot Work of TCM Formula Granules", and the formulation of national drug standards for TCM formula granules is also on the agenda.
According to the interpretation of the State Food and Drug Administration, the first batch of 160 Chinese medicine formula granules national standards will be released soon.
The formulation of the first batch of national standards for traditional Chinese medicine formula granules implements the management concepts and requirements of "full process management", "standard decoction comparison" and "establishing rigorous quality standards" in the "Technical Requirements for Quality Control and Standard Formulation of Traditional Chinese Medicine Formula Granules".
The goal is to form the "most rigorous standard.
"
The formulation of the first batch of national standards for traditional Chinese medicine formula granules implements the management concepts and requirements of "full process management", "standard decoction comparison" and "establishing rigorous quality standards" in the "Technical Requirements for Quality Control and Standard Formulation of Traditional Chinese Medicine Formula Granules".
The goal is to form the "most rigorous standard.
"
The first batch of national standards for traditional Chinese medicine formula granules has the following five characteristics:
1.
Clarify the varieties of multi-base raw medicinal materials , so that the source of Chinese medicine bases can be controlled more accurately.
Clarify the varieties of multi-base raw medicinal materials , so that the source of Chinese medicine bases can be controlled more accurately.
2.
Fully embody the traditional technique of decoction and ensure that the decoction pieces are fed in sufficient quantities.
Fully embody the traditional technique of decoction and ensure that the decoction pieces are fed in sufficient quantities.
3.
It can effectively distinguish the authenticity of Chinese medicine formula granules and realize the overall quality control of Chinese medicine.
It can effectively distinguish the authenticity of Chinese medicine formula granules and realize the overall quality control of Chinese medicine.
4.
Fully implement the requirements of the new version of "Chinese Pharmacopoeia" for harmful foreign residues, so that Chinese medicine formula granules are more safe.
Fully implement the requirements of the new version of "Chinese Pharmacopoeia" for harmful foreign residues, so that Chinese medicine formula granules are more safe.
5.
Reasonably stipulate the conditions of storage and circulation links to better guarantee the quality of traditional Chinese medicine formula granules.
Reasonably stipulate the conditions of storage and circulation links to better guarantee the quality of traditional Chinese medicine formula granules.
New standards and high requirements, pharmaceutical companies face a new test
The requirements of national standards for enterprises are mainly reflected in two aspects.
One is the requirement for the scale of the enterprise.
The production of Chinese medicine formula granules should follow the concept of whole-process control.
Manufacturers should give priority to the use of Chinese medicinal materials from Chinese medicinal materials planting and breeding bases that meet the requirements of Chinese medicinal materials production quality management standards.
It is recommended to use authentic medicinal materials and self-processed for Chinese medicine formulas.
The decoction pieces of traditional Chinese medicine produced by granules have the complete production capacity of traditional Chinese medicine processing, extraction, separation, concentration, drying, and granulation.
Manufacturers should give priority to the use of Chinese medicinal materials from Chinese medicinal materials planting and breeding bases that meet the requirements of Chinese medicinal materials production quality management standards.
It is recommended to use authentic medicinal materials and self-processed for Chinese medicine formulas.
The decoction pieces of traditional Chinese medicine produced by granules have the complete production capacity of traditional Chinese medicine processing, extraction, separation, concentration, drying, and granulation.
Enterprises are required to have a supporting planting base of Chinese medicinal materials, strengthen the research on the processing technology of Chinese medicinal pieces, the construction of Chinese medicinal materials planting bases, and source control.
The second is the ability to control corporate quality.
In the technical requirements, the concept of "standard decoction" was introduced, and the application of characteristic map quality control technology was stipulated, which strengthened the overall quality control level of traditional Chinese medicine formula granules.
On the basis of the study of exogenous and other harmful residues, unified requirements for pesticide residues, heavy metals and harmful elements, mycotoxins, etc.
, refer to the 2020 edition of the Chinese Pharmacopoeia.
On the basis of the study of exogenous and other harmful residues, unified requirements for pesticide residues, heavy metals and harmful elements, mycotoxins, etc.
, refer to the 2020 edition of the Chinese Pharmacopoeia.
Higher standards will also bring higher costs, which substantially raises the threshold of the Chinese medicine formula granule market.
Although the TCM granule industry has a large number of entrants, only a few can do it on a large scale.
In order to achieve profitability, Chinese medicine formula granule companies need to work together to form an "integrated" scale advantage from the procurement of medicinal materials, process technology to production, quality control, and sales terminals.
In order to achieve profitability, Chinese medicine formula granule companies need to work together to form an "integrated" scale advantage from the procurement of medicinal materials, process technology to production, quality control, and sales terminals.
It is understood that the current Chinese medicine formula granule companies are mainly composed of 6 pilot companies across the country and the gradually opening provincial pilot companies.
The 6 pilot companies account for more than 80% of the market share.
The industry concentration is extremely high, but the industry competition is becoming increasingly fierce.
The 6 pilot companies account for more than 80% of the market share.
The industry concentration is extremely high, but the industry competition is becoming increasingly fierce.
(Source: Compiled by Qianzhan Industry Research Institute)
Large-scale Chinese medicine formula granule companies have established an integrated upstream and downstream industrial platform by opening up the entire industry chain, establishing their own medicinal material cultivation bases and Chinese medicine decoction pieces trading market, stabilizing the quality of Chinese medicine decoction pieces, and strictly controlling product quality from source to sales.
Form a stable and controllable production and sales model for the entire industry chain.
Form a stable and controllable production and sales model for the entire industry chain.
In the past, there have been many companies in the traditional Chinese medicine formula granule industry, but there are only more than 20 companies that really have large-scale product sales.
Most companies have no large-scale product sales, and their licenses are basically in an "idle" state.
Now that the new standard is about to be introduced, there are higher requirements for the scale of the enterprise.
Most companies have no large-scale product sales, and their licenses are basically in an "idle" state.
Now that the new standard is about to be introduced, there are higher requirements for the scale of the enterprise.
The blue ocean of the tens of billions market, many pharmaceutical companies are vying for the first layout
Although the Chinese medicine formula granule market is currently highly concentrated, it still attracts a large number of pharmaceutical companies to enter the market due to the huge market prospects.
Since February last year, a number of listed companies have set up production bases for traditional Chinese medicine formula granules.
According to incomplete statistics from Xinhua News Agency, there are currently more than 60 pharmaceutical companies across the country that have obtained the qualifications for the production of traditional Chinese medicine prescription granules, including the six trial-manufacturing enterprises of Chinese medicine prescription granules initially approved by the State Food and Drug Administration.
According to incomplete statistics from Xinhua News Agency, there are currently more than 60 pharmaceutical companies across the country that have obtained the qualifications for the production of traditional Chinese medicine prescription granules, including the six trial-manufacturing enterprises of Chinese medicine prescription granules initially approved by the State Food and Drug Administration.
On the one hand, traditional Chinese medicine formula granules have a larger sales space than ordinary medicines , and there is no need to participate in national centralized procurement.
Some hospitals can also refer to Chinese medicine decoction pieces into the scope of medical insurance reimbursement.
On the other hand, the superimposed traditional Chinese medicine formula particles are more convenient to carry and equivalent to the efficacy of traditional Chinese medicine preparations.
With the deepening of patient education, the market scale will continue to expand.
Some hospitals can also refer to Chinese medicine decoction pieces into the scope of medical insurance reimbursement.
On the other hand, the superimposed traditional Chinese medicine formula particles are more convenient to carry and equivalent to the efficacy of traditional Chinese medicine preparations.
With the deepening of patient education, the market scale will continue to expand.
According to the analysis of iiMedia.
com, the market size of traditional Chinese medicine formula granules increased from 200 million yuan to 10.
7 billion yuan from 2006 to 2016, with a compound annual growth rate of 48.
9%.
It is expected that the market size of traditional Chinese medicine formula granules will reach 25.
5 billion yuan by 2020.
Some institutions predict that the market size of the Chinese medicine formula granule industry will continue to grow rapidly in the next five years.
It is estimated that by 2023, the industry size will reach 49.
21 billion yuan.
com, the market size of traditional Chinese medicine formula granules increased from 200 million yuan to 10.
7 billion yuan from 2006 to 2016, with a compound annual growth rate of 48.
9%.
It is expected that the market size of traditional Chinese medicine formula granules will reach 25.
5 billion yuan by 2020.
Some institutions predict that the market size of the Chinese medicine formula granule industry will continue to grow rapidly in the next five years.
It is estimated that by 2023, the industry size will reach 49.
21 billion yuan.
2006-2020 market scale and forecast of traditional Chinese medicine formula granules (unit: 100 million yuan)
(Data source: National Bureau of Statistics, iiMedia Data Center)
With the introduction of unified standards, problems that restrict the development of the industry, such as market chaos and repeated waste of research and development, will be resolved.
Future competition requires participation in compliance, competition in technology, and endorsement of strength.
In addition, with the end of the pilot policy, competition in the Chinese medicine formula granule market will become more intense in the future, and the existing pattern is expected to be broken.
Future competition requires participation in compliance, competition in technology, and endorsement of strength.
In addition, with the end of the pilot policy, competition in the Chinese medicine formula granule market will become more intense in the future, and the existing pattern is expected to be broken.
At present, the traditional Chinese medicine formula granule industry is still in its infancy.
The first thing pharmaceutical companies must do is to keep up with policy trends and continuously improve their quality-centric competitiveness in order to share more shares in this tens of billions of market.
The first thing pharmaceutical companies must do is to keep up with policy trends and continuously improve their quality-centric competitiveness in order to share more shares in this tens of billions of market.
Medical News February 22
The introduction of the heavy policy, the 20 billion market is facing the changing situation
The introduction of the heavy policy, the 20 billion market is facing the changing situation On February 18, the website of the State Food and Drug Administration published a number of articles on the development of TCM formula granules to further interpret the importance of the formulation of national standards for TCM formula granules.
The national standard of Chinese medicine formula granules will be promulgated soon
The national standard of Chinese medicine formula granules will be promulgated soon A few days ago, the State Food and Drug Administration, the State Administration of Traditional Chinese Medicine , the National Health Commission, and the National Medical Insurance Administration jointly issued the "Announcement on Ending the Pilot Work of TCM Formula Granules", and the formulation of national drug standards for TCM formula granules is also on the agenda.
Medicine Medicine Medicine According to the interpretation of the State Food and Drug Administration, the first batch of 160 Chinese medicine formula granules national standards will be released soon.
The formulation of the first batch of national standards for traditional Chinese medicine formula granules implements the management concepts and requirements of "full process management", "standard decoction comparison" and "establishing rigorous quality standards" in the "Technical Requirements for Quality Control and Standard Formulation of Traditional Chinese Medicine Formula Granules".
The goal is to form the "most rigorous standard.
"
The formulation of the first batch of national standards for traditional Chinese medicine formula granules implements the management concepts and requirements of "full process management", "standard decoction comparison" and "establishing rigorous quality standards" in the "Technical Requirements for Quality Control and Standard Formulation of Traditional Chinese Medicine Formula Granules".
The goal is to form the "most rigorous standard.
"
The first batch of national standards for traditional Chinese medicine formula granules has the following five characteristics:
The first batch of national standards for traditional Chinese medicine formula granules has the following five characteristics: 1.
Clarify the varieties of multi-base raw medicinal materials , so that the source of Chinese medicine bases can be controlled more accurately.
Herbs medicinal herbsClarify the varieties of multi-base raw medicinal materials , so that the source of Chinese medicine bases can be controlled more accurately.
2.
Fully embody the traditional technique of decoction and ensure that the decoction pieces are fed in sufficient quantities.
Fully embody the traditional technique of decoction and ensure that the decoction pieces are fed in sufficient quantities.
3.
It can effectively distinguish the authenticity of Chinese medicine formula granules and realize the overall quality control of Chinese medicine.
It can effectively distinguish the authenticity of Chinese medicine formula granules and realize the overall quality control of Chinese medicine.
4.
Fully implement the requirements of the new version of "Chinese Pharmacopoeia" for harmful foreign residues, so that Chinese medicine formula granules are more safe.
Fully implement the requirements of the new version of "Chinese Pharmacopoeia" for harmful foreign residues, so that Chinese medicine formula granules are more safe.
5.
Reasonably stipulate the conditions of storage and circulation links to better guarantee the quality of traditional Chinese medicine formula granules.
Reasonably stipulate the conditions of storage and circulation links to better guarantee the quality of traditional Chinese medicine formula granules.
New standards and high requirements, pharmaceutical companies face a new test
New standards and high requirements, pharmaceutical companies face a new testThe requirements of national standards for enterprises are mainly reflected in two aspects.
Enterprise business enterprise One is the requirement for the scale of the enterprise.
The production of Chinese medicine formula granules should follow the concept of whole-process control.
Manufacturers should give priority to the use of Chinese medicinal materials from Chinese medicinal materials planting and breeding bases that meet the requirements of Chinese medicinal materials production quality management standards.
It is recommended to use authentic medicinal materials and self-processed for Chinese medicine formulas.
The decoction pieces of traditional Chinese medicine produced by granules have the complete production capacity of traditional Chinese medicine processing, extraction, separation, concentration, drying, and granulation.
Manufacturers should give priority to the use of Chinese medicinal materials from Chinese medicinal materials planting and breeding bases that meet the requirements of Chinese medicinal materials production quality management standards.
It is recommended to use authentic medicinal materials and self-processed for Chinese medicine formulas.
The decoction pieces of traditional Chinese medicine produced by granules have the complete production capacity of traditional Chinese medicine processing, extraction, separation, concentration, drying, and granulation.
Enterprises are required to have a supporting planting base of Chinese medicinal materials, strengthen the research on the processing technology of Chinese medicinal pieces, the construction of Chinese medicinal materials planting bases, and source control.
The second is the ability to control corporate quality.
In the technical requirements, the concept of "standard decoction" was introduced, and the application of characteristic map quality control technology was stipulated, which strengthened the overall quality control level of traditional Chinese medicine formula granules.
On the basis of the study of exogenous and other harmful residues, unified requirements for pesticide residues, heavy metals and harmful elements, mycotoxins, etc.
, refer to the 2020 edition of the Chinese Pharmacopoeia.
On the basis of the study of exogenous and other harmful residues, unified requirements for pesticide residues, heavy metals and harmful elements, mycotoxins, etc.
, refer to the 2020 edition of the Chinese Pharmacopoeia.
Higher standards will also bring higher costs, which substantially raises the threshold of the Chinese medicine formula granule market.
Although the TCM granule industry has a large number of entrants, only a few can do it on a large scale.
In order to achieve profitability, Chinese medicine formula granule companies need to work together to form an "integrated" scale advantage from the procurement of medicinal materials, process technology to production, quality control, and sales terminals.
In order to achieve profitability, Chinese medicine formula granule companies need to work together to form an "integrated" scale advantage from the procurement of medicinal materials, process technology to production, quality control, and sales terminals.
It is understood that the current Chinese medicine formula granule companies are mainly composed of 6 pilot companies across the country and the gradually opening provincial pilot companies.
The 6 pilot companies account for more than 80% of the market share.
The industry concentration is extremely high, but the industry competition is becoming increasingly fierce.
The 6 pilot companies account for more than 80% of the market share.
The industry concentration is extremely high, but the industry competition is becoming increasingly fierce.
(Source: Compiled by Qianzhan Industry Research Institute)
Large-scale Chinese medicine formula granule companies have established an integrated upstream and downstream industrial platform by opening up the entire industry chain, establishing their own medicinal material cultivation bases and Chinese medicine decoction pieces trading market, stabilizing the quality of Chinese medicine decoction pieces, and strictly controlling product quality from source to sales.
Form a stable and controllable production and sales model for the entire industry chain.
Form a stable and controllable production and sales model for the entire industry chain.
In the past, there have been many companies in the traditional Chinese medicine formula granule industry, but there are only more than 20 companies that really have large-scale product sales.
Most companies have no large-scale product sales, and their licenses are basically in an "idle" state.
Now that the new standard is about to be introduced, there are higher requirements for the scale of the enterprise.
Most companies have no large-scale product sales, and their licenses are basically in an "idle" state.
Now that the new standard is about to be introduced, there are higher requirements for the scale of the enterprise.
The blue ocean of the tens of billions market, many pharmaceutical companies are vying for the first layout
The blue ocean of the tens of billions market, many pharmaceutical companies are vying for the first layout Although the Chinese medicine formula granule market is currently highly concentrated, it still attracts a large number of pharmaceutical companies to enter the market due to the huge market prospects.
Since February last year, a number of listed companies have set up production bases for traditional Chinese medicine formula granules.
According to incomplete statistics from Xinhua News Agency, there are currently more than 60 pharmaceutical companies across the country that have obtained the qualifications for the production of traditional Chinese medicine prescription granules, including the six trial-manufacturing enterprises of Chinese medicine prescription granules initially approved by the State Food and Drug Administration.
According to incomplete statistics from Xinhua News Agency, there are currently more than 60 pharmaceutical companies across the country that have obtained the qualifications for the production of traditional Chinese medicine prescription granules, including the six trial-manufacturing enterprises of Chinese medicine prescription granules initially approved by the State Food and Drug Administration.
On the one hand, traditional Chinese medicine formula granules have a larger sales space than ordinary medicines , and there is no need to participate in national centralized procurement.
Some hospitals can also refer to Chinese medicine decoction pieces into the scope of medical insurance reimbursement.
On the other hand, the superimposed traditional Chinese medicine formula particles are more convenient to carry and equivalent to the efficacy of traditional Chinese medicine preparations.
With the deepening of patient education, the market scale will continue to expand.
Medicine medicine medicine hospital hospital hospitalSome hospitals can also refer to Chinese medicine decoction pieces into the scope of medical insurance reimbursement.
On the other hand, the superimposed traditional Chinese medicine formula particles are more convenient to carry and equivalent to the efficacy of traditional Chinese medicine preparations.
With the deepening of patient education, the market scale will continue to expand.
According to the analysis of iiMedia.
com, the market size of traditional Chinese medicine formula granules increased from 200 million yuan to 10.
7 billion yuan from 2006 to 2016, with a compound annual growth rate of 48.
9%.
It is expected that the market size of traditional Chinese medicine formula granules will reach 25.
5 billion yuan by 2020.
Some institutions predict that the market size of the Chinese medicine formula granule industry will continue to grow rapidly in the next five years.
It is estimated that by 2023, the industry size will reach 49.
21 billion yuan.
com, the market size of traditional Chinese medicine formula granules increased from 200 million yuan to 10.
7 billion yuan from 2006 to 2016, with a compound annual growth rate of 48.
9%.
It is expected that the market size of traditional Chinese medicine formula granules will reach 25.
5 billion yuan by 2020.
Some institutions predict that the market size of the Chinese medicine formula granule industry will continue to grow rapidly in the next five years.
It is estimated that by 2023, the industry size will reach 49.
21 billion yuan.
2006-2020 market scale and forecast of traditional Chinese medicine formula granules (unit: 100 million yuan)
(Data source: National Bureau of Statistics, iiMedia Data Center)
With the introduction of unified standards, problems that restrict the development of the industry, such as market chaos and repeated waste of research and development, will be resolved.
Future competition requires participation in compliance, competition in technology, and endorsement of strength.
In addition, with the end of the pilot policy, competition in the Chinese medicine formula granule market will become more intense in the future, and the existing pattern is expected to be broken.
Future competition requires participation in compliance, competition in technology, and endorsement of strength.
In addition, with the end of the pilot policy, competition in the Chinese medicine formula granule market will become more intense in the future, and the existing pattern is expected to be broken.
At present, the traditional Chinese medicine formula granule industry is still in its infancy.
The first thing pharmaceutical companies must do is to keep up with policy trends and continuously improve their quality-centric competitiveness in order to share more shares in this tens of billions of market.
The first thing pharmaceutical companies must do is to keep up with policy trends and continuously improve their quality-centric competitiveness in order to share more shares in this tens of billions of market.
